Evidence map›Paper›PMID 40940646›Full record

ArticleAddiction science & clinical practice2025

Rural providers' attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest.

Phillip L Marotta, Miryam Biaid, Robert Heimer, Debbie Humphries, Katie Wang, Nithya Narayanan, Zach Lynch, Virginia McKay, Hilary Reno, Rachel Winograd and 5 more

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Phillip L MarottaBrown School, Washington University, St. Louis, MO, USA. phillip.marotta@wustl.edu.ORCID 0000-0002-5799-1736
Miryam BiaidBrown School, Washington University, St. Louis, MO, USA.
Robert HeimerYale School of Public Health, New Haven, CT, USA.
Debbie HumphriesYale School of Public Health, New Haven, CT, USA.
Katie WangDepartment of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA.
Nithya NarayananYale School of Public Health, New Haven, CT, USA.
Zach LynchYale School of Public Health, New Haven, CT, USA.
Virginia McKaySchool of Public Health, Washington University, St. Louis, MO, USA.
Hilary RenoSchool of Public Health, Washington University, St. Louis, MO, USA.
Rachel WinogradDepartment of Psychological Sciences, University of Missouri, St. Louis, MO, USA.
Dawn Goddard-EckrichColumbia University School of Social Work, New York, NY, USA.
Lindsey FiliatreauSchool of Public Health, Washington University, St. Louis, MO, USA.
Kristi StringerDepartment of Health and Human Performance, Middle Tennessee State University, Murfreesboro, TN, USA.
Kaileigh BackesBrown School, Washington University, St. Louis, MO, USA.
Patricia Cavazos-RehgSchool of Medicine, Washington University, St. Louis, MO, USA.

Funding

Mental illness stigma as a risk factor for substance use among adults with depressionK01DA045738 · NIDA · YALE UNIVERSITY · PI WANG, PENG · 2019 to 2023
$886k
Designing adaptive implementation strategies for mental health care in persons living with HIV in South Africa (DASH-SA)K01MH136924 · NIMH · WASHINGTON UNIVERSITY · PI Lindsey Filiatreau · 2024 to 2026
$537k
Intersectional stigma among rural buprenorphine providers as a barrier to diffusion of harm reduction strategies and interventions to enhance engagement in treatment for HIV and opioid use disordersR21DA057136 · NIDA · WASHINGTON UNIVERSITY · PI MAROTTA, PHILLIP L · 2022 to 2023
$458k
NIDA NIH HHS K01DA045738NIDA NIH HHS K12041449NIDA NIH HHS R21DA057136NIDA NIH HHS R25037190NIMH NIH HHS K01 MH136924
6 · The paper itself

Abstract

backgroundPeople with opioid use disorders (OUD) living in the South and Midwest are under-prescribed pre-exposure prophylaxis (PrEP) despite an increasing number of providers writing PrEP prescriptions in other regions of the United States. Greater research is needed into attitudes toward integrating harm reduction strategies into primary care and PrEP prescribing among prescribers working in rural primary care settings. The objective of this paper was to examine relationships between providers' attitudes toward buprenorphine and methadone, comprehensive harm reduction (e.g., fentanyl test strips) and self-reported PrEP prescribing in the past year.

methodsRelationships were examined between attitudes toward buprenorphine and harm reduction services, and PrEP prescribing among 409 rural primary health care providers (PCPs) treating at least one person with OUD or HIV in several EHE priority states. A Qualtrics panel survey was administered to primary care providers residing in the U.S. South and Midwest and worked in a Federally Qualified Health Center, Rural Health Clinic or other HRSA-eligible health center. Chi-square tests were used to explore significant differences between PrEP prescribers and non-Prescribers on attitudes toward integrating MOUD, drug-related harm reduction into primary care.

resultsOverall, 62.1% (n = 254) of the sample of providers reported writing at least one prescription for PrEP in the past year. Providers who believed that reforming buprenorphine waiver laws made their jobs easier or who expressed interest in integrating naloxone distribution and syringe exchange into primary care were more likely to write prescriptions for PrEP compared to providers who did not have these beliefs. Providers who were from larger facilities and who had specialty training in infectious diseases were more likely to write prescriptions for PrEP.

conclusionsFindings from this study suggest that providers who are more open to integrating harm reduction services into primary care are more likely to prescribe PrEP in the past year. PCPs with more positive attitudes toward naloxone, syringe exchange, and buprenorphine were more likely to prescribe PrEP in the past year. Combination interventions may be a promising avenue of reducing the harms of drug use including overdose and HIV infection among populations of people who use drugs.

Indexed as

Attitude of Health PersonnelHarm ReductionOpioid-Related DisordersPractice Patterns, Physicians'Pre-Exposure ProphylaxisPrimary Health CareRural Health ServicesAdultBuprenorphineFemaleHIV InfectionsHumansMaleMethadoneMiddle AgedMidwestern United StatesBuprenorphineMethadoneNarcotic Antagonists

Identifiers

PMID40940646
PMCPMC12427098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.